Document/ExhibitDescriptionPagesSize 1: 8-K Current Report HTML 52K
5: R1 Cover Page HTML 48K
7: XML IDEA XML File -- Filing Summary XML 11K
10: XML XBRL Instance -- pnr-20240507_htm XML 14K
6: EXCEL IDEA Workbook of Financial Report Info XLSX 8K
3: EX-101.LAB XBRL Labels -- pnr-20240507_lab XML 66K
4: EX-101.PRE XBRL Presentations -- pnr-20240507_pre XML 35K
2: EX-101.SCH XBRL Schema -- pnr-20240507 XSD 10K
8: JSON XBRL Instance as JSON Data -- MetaLinks 12± 17K
9: ZIP XBRL Zipped Folder -- 0000077360-24-000024-xbrl Zip 165K
(State
or other jurisdiction of incorporation or organization)
(Commission File No.)
(I.R.S. Employer Identification No.)
iRegal House, i70 London Road, iTwickenham,
London, iTW13QSiUnited Kingdom
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code:i44-i74-i9421-6154
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
i☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
i☐
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
i☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
i☐
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
iOrdinary Shares, nominal value $0.01 per share
iPNR
iNew
York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act (17 CFR 230.405) or Rule 12b-2 of the Exchange Act (17 CFR 240.12b-2). i☐Emerging growth company
If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
ITEM 5.07 Submission of Matters to a Vote of Security Holders.
Pentair plc (the “Company”) held its 2024 annual general meeting of shareholders on May
7, 2024. There were 166,016,097 ordinary shares issued and outstanding at the close of business on March 8, 2024 and entitled to vote at the annual general meeting. A total of 146,625,794 ordinary shares (88.32%) were represented at the annual general meeting.
The items voted upon at the annual general meeting and the results of the vote on each proposal were as follows:
Proposal 1. — Re-Elect Director Nominees
To re-elect ten director nominees for one-year terms expiring at the 2025 annual general meeting of shareholders. Each nominee for director was re-elected by a vote of the shareholders as follows:
Nominees
Votes
For
Votes Against
Abstentions
Broker Non-Votes
Mona Abutaleb Stephenson
136,806,285
1,422,695
92,667
8,304,147
Melissa Barra
136,986,667
1,244,632
90,348
8,304,147
Tracey
C. Doi
137,783,988
445,310
92,349
8,304,147
T. Michael Glenn
118,872,426
19,353,143
96,078
8,304,147
Theodore L. Harris
132,751,534
5,476,589
93,524
8,304,147
David
A. Jones
125,726,982
12,500,039
94,626
8,304,147
Gregory E. Knight
137,026,384
1,201,846
93,417
8,304,147
Michael T. Speetzen
135,271,064
2,957,590
92,993
8,304,147
John
L. Stauch
135,809,197
2,421,045
91,405
8,304,147
Billie I. Williamson
130,182,079
8,051,021
88,547
8,304,147
Proposal 2. — Approve, by Nonbinding, Advisory Vote, the Compensation of the Named Executive Officers
To approve, by nonbinding, advisory vote, the compensation of the
Company’s named executive officers. The compensation of the Company’s named executive officers was approved by a nonbinding, advisory vote of the shareholders as follows:
Votes For
Votes Against
Abstentions
Broker Non-Votes
123,848,121
14,278,009
195,517
8,304,147
Proposal
3. — Ratify, by Nonbinding, Advisory Vote, the Appointment of Deloitte & Touche LLP as the Independent Auditor of the Company and to Authorize, by Binding Vote, the Audit and Finance Committee of the Board of Directors to Set the Auditor’s Remuneration
To ratify, by nonbinding, advisory vote, the appointment of Deloitte & Touche LLP as the Company’s independent auditor for the year ending December 31, 2024 and to authorize, by binding vote, the Audit and Finance Committee of the Board of Directors to set the independent auditor’s remuneration. The proposal was approved by a vote of the shareholders as follows:
Votes
For
Votes Against
Abstentions
131,801,509
14,725,193
99,092
Proposal 4. — Authorize the Board of Directors to Allot New Shares Under Irish Law
To authorize the Board of Directors to allot new shares under Irish law. The proposal was approved by a vote of the shareholders as follows:
Votes
For
Votes Against
Abstentions
144,034,624
2,355,907
235,263
Proposal 5. — Authorize the Board of Directors to Opt-Out of Statutory Preemption Rights Under Irish Law
To authorize the Board of Directors to opt-out of statutory preemption rights under Irish law. The proposal was approved by a vote of the shareholders as follows:
Votes
For
Votes Against
Abstentions
121,316,120
25,027,179
282,495
Proposal 6. — Authorize the Price Range at Which the Company Can Re-Allot Shares It Holds as Treasury Shares Under Irish Law
To authorize the price range at which the Company can re-allot shares it holds as treasury shares under Irish law.
The proposal was approved by a vote of the shareholders as follows:
Votes For
Votes Against
Abstentions
145,820,942
578,504
226,348
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, on May 7, 2024.
